Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First patient dosed with dalbavancin in S. aureus bacteremia trial

europeanpharmaceuticalreviewApril 29, 2021

Tag: Dalbavancin , S. aureus , Antibiotic

PharmaSources Customer Service